# Tootsie Roll Industries Inc: Form 10-Q for the period ended Sep 30, 2018

- Company: [Tootsie Roll Industries Inc](/companies/tr.md) (CIK 98677)
- Form: 10-Q
- Filed: 2018-11-09
- Accepted by EDGAR: Nov 9, 2018, 06:08 ET
- Period: 2018-09-30
- Accession: 0001558370-18-009091
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/98677/000155837018009091/tr-20180930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/98677/000155837018009091/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $182.3m | us-gaap:Revenues |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $390.9m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $115.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $249.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $66.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $141.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2018-07-01 to 2018-09-30 | $36.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-01-01 to 2018-09-30 | $91.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $30.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $50.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | $7.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $12.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-07-01 to 2018-09-30 | $26.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-01-01 to 2018-09-30 | $44.7m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | $0.70 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | $41.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $16.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-01-01 to 2018-09-30 | $17.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2018-01-01 to 2018-09-30 | $16.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-09-30 | $64.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $302.3m | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $960.8m | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $74.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2018-09-30 | $746.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,970 characters.

This financial review discusses the Company’s financial condition, results of operations, liquidity and capital resources and other matters. Dollars are presented in thousands, except per share amounts. This review should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and related notes included in this Form 10-Q and with the Company’s Consolidated Financial Statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Form 10-K for the year ended December 31, 2017 (the “2017 Form 10-K”).

Net product sales were $181,505 in third quarter 2018 compared to $182,173 in third quarter 2017, a decrease of $668 or 0.4%. Nine months 2018 net product sales were $387,987 compared to $390,495 in nine months 2017, a decrease of $2,508 or 0.6%. The timing of certain sales between second and third quarter in the comparative 2018 and 2017 periods caused third quarter 2018 net product sales to edge lower than third quarter 2017 net product sales.

Product cost of goods sold were $115,246 in third quarter 2018 compared to $114,970 in third quarter 2017, and nine months 2018 product cost of goods sold were $248,561 compared to $245,889 in nine months 2017. Product cost of goods sold includes $83 and $560 of certain deferred compensation expenses in third quarter 2018 and 2017, respectively, and $150 and $1,845 of certain deferred compensation expenses in nine months 2018 and 2017, respectively. These deferred compensation expenses principally result from the changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, product cost of goods sold increased from $114,410 in third quarter 2017 to $115,163 in third quarter 2018, an increase of $753 or 0.7%; and increased from $244,044 in nine months 2017 to $248,411 in nine months 2018, an increase of $4,367 or 1.8%. As a percentage of net product sales, adjusted product cost of goods sold was 63.5% and 62.8% in third quarter 2018 and 2017, respectively, an unfavorable increase of 0.7 percentage points; and adjusted product cost of goods sold was 64.0% and 62.5% in nine months 2018 and 2017, respectively, an unfavorable increase of 1.5 percentage points. Increases in wages and employee healthcare and other benefit costs, principally resulting from unfavorable experience under Company self-insurance programs, added to third quarter and nine months 2018 product cost of goods sold. Increases in plant manufacturing overhead costs, including higher repairs and maintenance, also contributed higher product cost of goods sold in third quarter and nine months 2018.

Costs relating to quality improvements in product packaging and start-up of new manufacturing packaging lines, which were substantially phased into service during the second and third quarters of 2018, also had an unfavorable impact on product cost of goods sold and resulting lower gross profit margins in third quarter and nine months 2018 compared to third quarter and nine months 2017. The Company is continuing its investments in its plant manufacturing operations and products to meet new consumer and customer demands, achieve quality improvements to increase consumer product acceptance, and realize operational efficiencies and cost reductions. Manufacturing efficiencies driven by capital investments and ongoing cost containment programs mitigated some of these higher costs and expenses discussed above.

Selling, marketing and administrative expenses were $36,620 in third quarter 2018 compared to $33,222 in third quarter 2017, and nine months 2018 selling, marketing and administrative expenses were $91,229 compared to $86,502 in nine months 2017. Selling, marketing and administrative expenses includes $2,267 and $1,717 of certain deferred compensation expenses in third quarter 2018 and 2017, and $4,215 and $5,131 of certain deferred compensation expenses in nine months 2018 and 2017, respectively. As discussed above, these expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years, and are not reflective of current operating results. Adjusting for the aforementioned, selling, marketing and administrative expenses increased from $31,505 in third quarter 2017 to $34,353 in third quarter 2018, an increase of $2,848 or 9.0%; and selling, marketing and administrative expenses increased from $81,371 in nine months 2017 to $87,014 in nine months 2018, an increase of $5,643 or 6.9%. As a percentage of net product sales, adjusted selling, marketing and administrative expenses increased from 17.3% in third quarter 2017 to 18.9% in third quarter 2018, an unfavorable increase of 1.6 percentage points as a percent of net sales, and selling, marketing and administrative expenses increased from 20.8% in nine months 2017 to 22.4% in nine months 2018, an unfavorable increase of 1.6 percentage points as a percent of net sales. The increase in adjusted selling, marketing and administrative expenses in third quarter and nine months 2018 principally reflects higher freight, delivery and warehousing expenses, which are discussed below, as well as increases in legal and professional fees expenses.

Selling, marketing and administrative expenses include $14,698 and $12,762 for customer freight, delivery and warehousing expenses in third quarter 2018 and 2017, respectively, an increase of $1,936 or 15.2%. These expenses were $36,304 and $31,857 in nine months 2018 and 2017, respectively, an increase of $4,447 or 14.0%. These increases in customer freight, delivery and warehousing expenses were the principal drivers of higher selling, marketing and administrative expenses in third quarter and nine months 2018. These expenses were 8.1% and 7.0% of net product sales in third quarter 2018 and 2017, respectively, and were 9.4% and 8.2% of net product sales in nine months 2018 and 2017, respectively. Increased freight and delivery expenses reflect higher freight rates principally due to increases in fuel costs and the continuing imbalance between supply and demand for over-the-road truck delivery. Much of this imbalance is being driven by a nationwide driver shortage as well as new federal regulations which require increased monitoring of a driver’s allowed driving time using electronic monitoring technology. Although the Company is taking steps to mitigate these higher freight and delivery costs, management believes that these higher input costs reflect a structural change in the transportation industry and are likely to continue.

Earnings from operations were $30,226 in third quarter 2018 compared to $34,583 in third quarter 2017, and were $50,436 in nine months 2018 compared to $60,118 in nine months 2017. Earnings from operations include $2,350 and $2,277 of certain deferred compensation expenses in third quarter 2018 and 2017, respectively, and include $4,365 and $6,976 of certain deferred compensation expenses in nine months 2018 and 2017, respectively, which are discussed above. Adjusting for these deferred compensation costs and expenses, operating earnings were $32,576 and $36,860 in third quarter 2018 and 2017, respectively, a decrease of $4,284 or 11.6%; and adjusted operating earnings were $54,801 and $67,094 in nine months 2018 and 2017, respectively, a decrease of $12,293 or 18.3%. As a percentage of net product sales, these adjusted operating earnings were 18.0% and 20.2% in third quarter 2018 and 2017, respectively, an unfavorable decrease of 2.2 percentage points as a percentage of net product sales; and as a percentage of net product sales, these adjusted operating earnings were 14.1% and 17.2% in nine months 2018 and 2017, respectively, an unfavorable decrease of 3.1 percentage points as a percentage of net product sales. This decline in operating earnings principally reflects increases in customer freight and delivery expenses and product costs of goods sold as discussed above. Management believes the presentation in this and the preceding paragraphs relating to amounts adjusted for deferred compensation expense are more reflective of the underlying operations of the Company.

It has been the historical experience in the confectionary industry that sale price increases are enacted when input costs and expense increases result in the erosion of margins. Company management believes that most companies and U.S. suppliers of branded confectionary products have recently announced selective sales price increases or product weight declines (indirect price increase). The Company has recently announced price increases that are effective January 1, 2019 for selective products and certain retail price points, and believes that these actions will mitigate some of the higher input costs and expenses, including freight and delivery, which are discussed above. The Company has not yet determined the amount of price realization that will ultimately result from this action.

Other income, net was $2,987 in third quarter 2018 compared to $4,370 in third quarter 2017, an unfavorable decrease of $1,383; and other income, net was $6,871 in nine months 2018 compared to $9,311 in nine months 2017, an unfavorable decrease of $2,440. Other income, net for third quarter 2018 and 2017 includes net gains and investment income of $2,350 and $2,277, respectively, on trading securities which provide an economic hedge of the Company’s deferred compensation liabilities; and other income, net for nine months 2018 and 2017 includes net gains and investment income of $4,365 and $6,976, respectively, on trading securities relating to these programs. These changes in trading securities were substantially offset by a like amount of deferred compensation expense included in product cost of goods sold and selling, marketing, and administrative expenses in the respective periods as discussed above. Other income, net includes gains (losses) on foreign exchange of $(506) and $1,082 in third quarter 2018 and 2017, respectively, and $(783) and $(527) in nine months 2018 and 2017, respectively.

The consolidated effective tax rates were 21.5% and 31.0% in third quarter 2018 and 2017, respectively, and 22.1% and 29.8% in nine months 2018 and 2017, respectively. The lower effective tax rate in third quarter and nine months 2018 compared to third quarter and nine months 2017 principally reflects the lower U.S. federal statutory tax rate of 21% effective as of January 1, 2018 resulting from U.S. tax reform legislation enacted in December 2017. As discussed in Note 3, the Company believes it has obtained and analyzed all reasonably available information necessary to record the effects of the change in tax law and considers its accounting for the effects of tax reform to be provisional as of September 30, 2018. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional regulatory guidance that may be issued.

Net earnings attributable to Tootsie Roll Industries, Inc. were $26,104 (after $25 net loss attributed to non-controlling interests) in third quarter 2018 compared to $26,933 (after $46 net loss attributed to non-controlling interests) in third quarter 2017, and earnings per share were $0.41 and $0.42 in third quarter 2018 and 2017, respectively, a decrease of $0.01 per share, or 2.4%. Nine months 2018 net earnings attributable to Tootsie Roll Industries, Inc. were $44,718 (after $68 net loss attributed to non-controlling interests) compared to nine months 2017 net earnings of $48,879 (after $131 net loss attributed to non-controlling interests), and net earnings per share were $0.70 and $0.75 in nine months 2018 and nine months 2017, respectively, a decrease of $0.05 per share or 6.7%. Earnings per share attributable to Tootsie Roll Industries, Inc. for third quarter and nine months 2018 did benefit from the reduction in average shares outstanding resulting from purchases in the open market by the Company of its common stock. Average shares outstanding decreased from 64,855 in third quarter 2017 to 64,155 in third quarter 2018, and from 65,155 in nine months 2017 to 64,268 in nine months 2018.

Goodwill and intangibles are assessed annually as of December 31 or whenever events or circumstances indicate that the carrying values may not be recoverable from future cash flows. The Company has not identified any triggering events, as defined, or other adverse information that would indicate a material impairment of its goodwill or intangibles in nine months 2018. There were also no impairments in the comparative nine months 2017 period or in calendar 2017.

As more fully discussed in Note 1, the Company adopted the new accounting revenue recognition guidance (ASC 606) effective January 1, 2018. As a result of adoption, the cumulative impact to retained earnings at January 1, 2018 was a net after-tax increase of $3,319 ($4,378 pre-tax). The adoption principally changed the timing of recognition of certain trade promotions and related adjustments thereto which affect net product sales. The comparative 2017 information has not been restated and continues to be reported under the accounting standards in effect for such period. The Company expects the impact of the adoption of the new standard to be immaterial to its net income in calendar 2018 and future years. Revenue for net product sales continues to be recognized at a point in time when products are delivered to or picked up by the customer, as designated by customers’ purchase orders, as discussed in Note 1.

Beginning in 2012, the Company received periodic notices from the Bakery and Confectionery Union and Industry International Pension Plan (Plan), a multi-employer defined benefit pension plan for certain Company union employees, that the Plan’s actuary certified the Plan to be in “critical status”, the “Red Zone”, as defined by the Pension Protection Act (PPA) and the Pension Benefit Guaranty Corporation (PBGC), and that a plan of rehabilitation was adopted by the trustees of the Plan in 2012 (and was further amended in 2016). During 2015, the Company received notices that the Plan’s status was changed to “critical and declining status”, as defined by the PPA and PBGC, for the plan year beginning January 1, 2015, and that the Plan was projected to have an accumulated funding deficiency for the 2017 through 2024 plan years. A designation of “critical and declining status” implies that the Plan is expected to become insolvent in the next 20 years. In April 2018, the Company received new updated notices that the Plan remains in “critical and declining status” and is currently projected to become insolvent in 2030. These notices also advise that the Plan trustees have updated the Rehabilitation Plan and are considering the reduction or elimination of certain retirement benefits as well as other plan restructuring that requires certain government approvals, with the goal of avoiding insolvency, but may ultimately seek assistance from the PBGC.

Based on updated annual notices, the Plan’s funded percentages (plan investment assets as a percentage of plan liabilities), as defined, were 54.7%, 57.0% and 62.8% as of January 1, 2017 (most recent valuation date available), 2016, and 2015, respectively (these valuation dates are as of the beginning of each Plan year). These funded percentages are based on actuarial values, as defined, and do not reflect the actual market value of Plan investments as of these dates. If the market value of investments had been used as of January 1, 2017, the funded percentage would be 52.5% (not 54.7%). As of the January 1, 2017 valuation date (most recent valuation available), 19% of Plan participants were current active employees, 52% were retired or separated from service and receiving benefits, and 29% were retired or separated from service and entitled to future benefits. The number of current active employee Plan participants as of January 1, 2017 fell 8% from the previous year and 9% over the past two years. When compared to the Plan valuation date of January 1, 2011 (six years earlier), current active employees participants have declined 36%, whereas participants who were retired or separated from service and receiving benefits increased 6% and participants who were retired or separated from service and entitled to future benefits increased 8%. The bankruptcy of a major participating employer in the Plan contributed to the above discussed Plan results. The Internal Revenue Service issued updated mortality tables (increasing life expectancy) effective January 1, 2018 which will likely increase the Plan’s liabilities and further decrease the above discussed funding percentages.

The Company has been advised that its withdrawal liability would have been $82,200, $72,700, and $61,000 if it had withdrawn from the Plan during 2017, 2016 and 2015, respectively. The increase from 2016 to 2017 principally reflects a decrease in the PBGC interest rates, a decrease in the Plan’s assets and an increase in the Plan’s unfunded vested benefits during 2016 with the Company comprising an increasing proportion of the Plan’s employer contribution base. Based on the above, including the Plan’s projected insolvency in the year 2030, management believes that the Company’s withdrawal liability will likely increase further in future years. Based on the Company’s actuarial study and certain provisions in ERISA and the law relating to withdrawal liability payments, management believes that the Company’s liability would likely be limited to twenty annual payments of $3,059 which have a present value in the range of $35,900 to $46,900 depending on the interest rate used to discount these payments. The aforementioned is based on a range of valuation interest rates which management understands is provided under the statute. Should the Company actually withdraw from the Plan at a future date, a withdrawal liability, which could be higher than the above discussed amounts, could be payable to the Plan.

The Company and the union have recently concluded a new labor contract which requires the Company’s continued participation in this Plan through September 2022. The amended rehabilitation plan, which also continues, requires that employer contributions include 5% compounded annual surcharge increases each year for an unspecified period of time beginning in 2012 as well as certain plan benefit reductions. The Company’s pension expense for this Plan for calendar 2017 and 2016 was $2,617 and $2,541, respectively. The aforementioned expense includes surcharges of $656 and $542 in 2017 and 2016, respectively, as required under the plan of rehabilitation as amended. The Company’s pension expense for this Plan for nine months 2018 and 2017 was $2,201 and $2,064 respectively, which includes surcharges of $630 and $517 respectively.

Earlier this year, the U.S. Congress formed a joint select committee to address the insolvency crisis affecting many multi-employer pension plans. The select committee is evaluating low-interest loans with government guarantees to these plans in order to provide long-term solvency to troubled multi-employer pension plans. The Company is currently unable to determine the ultimate outcome of the above discussed matter and, therefore, is unable to determine the effects on its consolidated financial statements, but the ultimate outcome or the effects of any modifications to the current or future rehabilitation plans or other changes, including a mass withdrawal of participating employers which would trigger the payment of the Company’s withdraw liability discussed above, could be material to its consolidated results of operations or cash flows in one or more future periods. See also the Company’s Consolidated Financial Statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2017 Form 10-K.

LIQUIDITY AND CAPITAL RESOURCES

Net cash flows provided by operating activities were $40,980 and $18,420 in nine months 2018 and 2017, respectively, a favorable increase of $22,560. The increase in nine months 2018 cash flows from operating activities principally reflects the timing of sales and collections of account receivables, the timing of payments (and refunds) of income taxes as well as lower income tax rates in 2018 as discussed above, and changes in accounts payable and accrued liabilities, prepaid expenses and other assets, and other receivables. The changes in accounts payable and accrued liabilities principally reflect the timing of purchases of packaging and ingredient inventory and vender payments. The change in prepaid expenses and other assets is primarily the result from the timing of payments for certain expenses, and the change in other receivables is primarily due to decreased broker margin deposit requirements on commodity sugar hedges.

Net cash used in investing activities was $39,521 in nine months 2018 compared to $42,149 in nine months 2017. Cash flows from investing activities reflect $65,098 and $51,935 of purchases of available for sale securities during nine months 2018 and 2017, respectively, and $45,379 and $21,328 of sales and maturities of available for sale securities during nine months 2018 and 2017, respectively. Nine months 2018 and 2017 investing activities include capital expenditures of $16,812 and $11,699, respectively. All capital expenditures in 2018 are expected to be funded from the Company’s cash flow from operations and internal sources. The increase in capital expenditures in nine months 2018 reflects the purchase of new packaging lines at several manufacturing plants. In addition, Company management has committed approximately $17,000 to a manufacturing plant rehabilitation upgrade and expansion of one of its manufacturing facilities in the U.S. Management expects the projected cash outlays for this project to be approximately $800 in 2018, $10,000 in 2019, $3,100 in 2020 and $3,100 in 2021.

The Company’s consolidated financial statements include bank borrowings of $190 and $404 at September 30, 2018 and 2017, respectively, all of which relates to its two majority-owned and controlled Spanish companies. The Company had no other outstanding bank borrowings at September 30, 2018.

Financing activities include Company common stock purchases and retirements of $16,650 and $30,027 in nine months 2018 and 2017, respectively. Cash dividends of $17,208 and $16,965 were paid in nine months 2018 and 2017, respectively.

The Company’s current ratio (current assets divided by current liabilities) was 4.1 to 1 at September 30, 2018 compared to 4.2 to 1 at December 31, 2017 and 3.8 to 1 at September 30, 2017. Net working capital was $227,766 at September 30, 2018 compared to $207,132 and $217,650 at December 31, 2017 and September 30, 2017, respectively. The aforementioned net working capital amounts are principally reflected in aggregate cash and cash equivalents and short-term investments of $132,706 at September 30, 2018 compared to $137,920 and $123,784 at December 31, 2017 and September 30, 2017, respectively. In addition, long term investments, principally debt securities comprising corporate and municipal bonds were $188,393 at September 30, 2018, as compared to $190,510 and $193,991 at December 31, 2017 and September 30, 2017, respectively. Aggregate cash and cash equivalents and short and long-term investments were $321,099, $328,430, and $317,775, at September 30, 2018, December 31, 2017 and September 30, 2017, respectively. The aforementioned includes $67,594, $60,520, and $75,094 at September 30, 2018, December 31, 2017 and September 30, 2017, respectively, relating to trading securities which are used as an economic hedge for the Company’s deferred compensation liabilities. Investments in corporate and municipal bonds, variable rate demand notes, and other debt securities that matured during nine months 2018 and 2017 were generally used to purchase the Company’s common stock or were replaced with debt securities of similar maturities.

The Company periodically contributes to a VEBA trust, managed and controlled by the Company, to fund the estimated future costs of certain employee health, welfare and other benefits. The Company is currently using these VEBA funds to pay the actual cost of such benefits through most of 2022. The VEBA trust held $17,152, $19,713 and $602 of aggregate cash and cash equivalents at September 30, 2018, December 31, 2017 and September 30, 2017, respectively. The Company contributed $20,024 to this VEBA trust in fourth quarter 2017. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 2 within the fair value hierarchy.

ACCOUNTING PRONOUNCEMENTS

See Note 1 of the Company’s Condensed Consolidated Financial Statements.

RISK FACTORS

There were no material changes to the risk factors disclosed in the Company’s 2017 Form 10-K.

FORWARD-LOOKING STATEMENTS

This discussion and certain other sections contain forward-looking statements that are based largely on the Company’s current expectations and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “anticipated,” “believe,” “expect,” “intend,” “estimate,” “project,” “plan” and other words of similar meaning in connection with a discussion of future operating or financial performance and are subject to certain factors, risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in the forward-looking statements. Such factors, risks, trends and uncertainties, which in some instances are beyond the Company’s control, include the overall competitive environment in the Company’s industry, changes in assumptions and judgments discussed above under the heading “Significant Accounting Policies and Estimates,” and factors identified and referred to above under the heading “Risk Factors” in this report and under the heading “Risk Factors” in the Company’s 2017 Form 10-K.

The risk factors identified and referred to above are believed to be significant factors, but not necessarily all of the significant factors that could cause actual results to differ from those expressed in any forward-looking statement. Readers are cautioned not to place undue reliance on such forward-looking statements, which are made only as of the date of this report. The Company undertakes no obligation to update such forward-looking statements.

## Market risk

As filed, 1,161 characters.

The Company is exposed to various market risks, including fluctuations in and sufficient availability of sugar, corn syrup, edible oils, including palm oils, cocoa, dextrose, milk and whey, and gum-base input ingredients and packaging, and fuel costs principally relating to freight and delivery fuel surcharges. The Company is exposed to exchange rate fluctuations in the Canadian dollar which is the currency used for a portion of the raw material and packaging material costs and all labor, benefits and local plant operating costs at its Canadian plants. The Company is exposed to exchange rate fluctuations in Mexico, Canada, and Spain where its subsidiaries sell products in their local currencies. The Company invests in securities with maturities dates of up to approximately three years which are generally held to maturity, and variable rate demand notes where interest rates are generally reset weekly, all of which limits the Company’s exposure to interest rate fluctuations. There have been no material changes in the Company’s market risks that would significantly affect the disclosures made in the Form 10-K for the year ended December 31, 2017.

## Controls and procedures

As filed, 1,325 characters.

Under the supervision and with the participation of management, the Chief Executive Officer and Chief Financial Officer of the Company have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2018 and, based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures are also designed to ensure that information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There has been no change in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ended September 30, 2018 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Filed Nov 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001558370-18-009091. Last ingested by Listed: Nov 6, 2026, 15:19 ET. No prices; not investment advice.
